Abstract:Purpose To investigate the expression of CD24 in cardiac adenocarcinoma, and to explore the relationship between the two molecules and other clinicopathological features. Methods The expression of CD24 in 140 cases of cardiac adenocarcinoma was detec-ted by using immunohistochemistry. And the relationship between CD24 and clinicopathological features, adenocarcinoma biological be-havior were analyzed, total RNAs were extracted from 26 cases of fresh carcinoma tissues and adjacent mucosa, each groups were divid-ed by different clinical staging, different degree of differentiation. The expression of CD24 was detected by using RT-PCR and the re-sults were shown as relative quantity. The difference of CD24 expression between two groups was further analyzed and the invasion of both groups was compared. Results Immunohistochemically, the expression of CD24 was significantly higher in carcinoma tissues than that in adjacent mucosa (P<0. 05), and those expression was associated with tumor differentiation (P<0. 05). CD24 was also closely related with the invasion, lymph node metastasis, clinical stages and nerves involvement (P<0. 05), while no relation with age, gender, vascular blots and residual situation (P>0. 05), the expression of CD24 in two pathological types showed that Lauren diffuse type was higher than intestinal type, the expression of CD24 was different among tubular adenocarcinoma, polypoid adenocarci-noma, mucinous adenocarcinoma and low adhesion adenocarcinoma (WHO classification) (P<0. 05). RT-PCR results demonstrated that the expression of CD24 was markedly higher in carcinoma tissues than those in adjacent mucosa ( P<0. 05 ) . The expression of CD24 in poorly differentiated adenocarcinoma was significantly higher than those in intermediate/highly differentiated adenocarcinoma (P<0. 05). CD24 expression was also associated with clinical stages. The relative quantity from stageⅠtoⅣwas progressively ris-ing (P<0. 05). Conclusions The expression of CD24 is closely related with the tumor differentiation, invasion, lymph node metas-tasis and clinical staging, suggesting that CD24 may be involved in the progression of cardiac adenocarcinoma, and the patients with higher CD24 expression may have poorer prognosis.

CD24: a Novel Cancer Biomarker in Laryngeal Squamous Cell Carcinoma.

CD24 is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery.

Clinicopathologic and Prognostic Significance of Cd24 in Gallbladder Carcinoma

Expression of CD24 As a Predictor of Prognosis of Hepatocellular Carcinoma after Operation

Expressions of SLeX and CD24 in laryngeal squamous cell carcinoma tissues

CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma

The expression and clinical significance of CD24 in human esophageal squamous cell carcinoma

CD24 As a Molecular Marker in Ovarian Cancer: A Literature Review

CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers

CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.

The clinical significance of Interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.

[Expression, roles and therapy target values of CD24 in oral squamous cell carcinoma].

CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma

Enhanced CD24 Expression in Colorectal Cancer Correlates with Prognostic Factors

CD 24 Promotes the Proliferation and Inhibits the Apoptosis of Cervical Cancer Cells in Vitro

CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy.

Expression of CD24 in cardiac adenocarcinoma and its clinical significance

Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma

The Role of Adhesion Molecule CD24 in Tumor Metastasis

Targeting CD24 as a novel immunotherapy for solid cancers

CD24 blockade as a novel strategy for cancer treatment